Diabetes, Digestive, and Kidney Diseases Extramural Research in Georgia
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $159 million to recipients in Georgia in 157 grants from fiscal 2021 to 2025, 1.7% of the program's national total. Emory University received the most, $85.4 million.
- Awarded in Georgia$159 million
- Awards157
- Share of the program1.7%
- Rank among states18th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 80 | $27.2 million |
| FY 2022 | 77 | $31.6 million |
| FY 2023 | 85 | $32.7 million |
| FY 2024 | 85 | $33.6 million |
| FY 2025 | 76 | $33.5 million |
Recipients in Georgia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Emory University | Colleges and universities | 92 | $85.4 million |
| Augusta University Research Institute, Inc | Nonprofits | 29 | $34.8 million |
| Georgia State University Research Foundation Inc | Nonprofits | 14 | $19.1 million |
| University of Georgia Research Foundation, Inc. | Nonprofits | 9 | $11.5 million |
| Georgia Tech Research Corp | Colleges and universities | 7 | $5.9 million |
| Nytricx, Inc. | Small businesses | 1 | $337,395 |
| Intailor Bariatrics, LLC | Small businesses | 1 | $325,408 |
| Inlighta Biosciences L.L.C. | Small businesses | 1 | $323,743 |
| Anxomics LLC | Small businesses | 1 | $312,492 |
| Hibar Microsciences, LLC | Small businesses | 1 | $299,999 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Georgia?
$159 million from fiscal 2021 to 2025, across 157 awards. Georgia ranks 18th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Georgia?
The largest recipient is Emory University, with $85.4 million in 92 awards. Next are Augusta University Research Institute, Inc and Georgia State University Research Foundation Inc.
Can organizations in Georgia apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Georgia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- 1332 State Innovation Waivers
- Children's Health Insurance Program
- Special Education Grants to States
- Temporary Assistance for Needy Families